These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 19924602)
1. Diabetes, obesity, insulin resistance: different pathways to cancer? Nawroth P Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):561-2. PubMed ID: 19924602 [No Abstract] [Full Text] [Related]
2. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes. Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917 [No Abstract] [Full Text] [Related]
4. Obesity and diabetes. Bompiani GD; Laudicina E Isr J Med Sci; 1972 Jun; 8(6):823-6. PubMed ID: 5051806 [No Abstract] [Full Text] [Related]
5. [Insulin resistance, obesity and diabetes. Mechanism of development and their mutual relations]. Klimes I; Ficková M Vnitr Lek; 1984 Dec; 30(12):1206-18. PubMed ID: 6395481 [No Abstract] [Full Text] [Related]
6. Use of sulfated insulin in insulin resistance. Bartle WR Am J Hosp Pharm; 1976 Sep; 33(9):874-9. PubMed ID: 984052 [No Abstract] [Full Text] [Related]
7. [Experimental obesity: study of resistance to insulin]. Le Marchand Y; Jeanrenaud B; Freychet P Journ Annu Diabetol Hotel Dieu; 1977; ():157-66. PubMed ID: 894860 [No Abstract] [Full Text] [Related]
9. The classification of diabetes mellitus: a conceptual framework. Ize-Ludlow D; Sperling MA Pediatr Clin North Am; 2005 Dec; 52(6):1533-52. PubMed ID: 16301082 [TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome--from insulin resistance to obesity and diabetes. Gallagher EJ; LeRoith D; Karnieli E Endocrinol Metab Clin North Am; 2008 Sep; 37(3):559-79, vii. PubMed ID: 18775352 [TBL] [Abstract][Full Text] [Related]
11. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus. Stefanović V; Antić S Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435 [TBL] [Abstract][Full Text] [Related]
12. [A new panorama for understanding the molecular connections between obesity and type 2 diabetes mellitus]. Fernández-Mejía C Rev Invest Clin; 2001; 53(3):209-11. PubMed ID: 11496706 [No Abstract] [Full Text] [Related]
13. [Insulin as vasoactive hormone. Significance for diabetes, obesity and hypertension]. Lind L; Berne C; Andersson PE; Lithell H Lakartidningen; 1997 Aug; 94(32-33):2730-2. PubMed ID: 9289582 [No Abstract] [Full Text] [Related]
14. [Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)]. Kochan Z; Karbowska J Przegl Lek; 2003; 60(1):40-2. PubMed ID: 12884646 [TBL] [Abstract][Full Text] [Related]
15. Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics. Lev-Ran AS Isr J Med Sci; 1971 Jun; 7(6):727-32. PubMed ID: 4997820 [No Abstract] [Full Text] [Related]
16. Insulin signaling in health and disease. White MF Science; 2003 Dec; 302(5651):1710-1. PubMed ID: 14657487 [TBL] [Abstract][Full Text] [Related]
17. Medical grand rounds from the West Virginia University Hospital. Insulin resistance. Jones DL W V Med J; 1979 Sep; 75(9):264-70. PubMed ID: 384675 [No Abstract] [Full Text] [Related]